NM1 for Symptomatic Cerebral Arteries Stenosis after stent Angioplasty: A Randomized controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800016555

Enrollment

Unknown

Registered

2018-06-08

Start date

2018-06-11

Completion date

Unknown

Last updated

2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Cerebral Artery Stenosis

Interventions

Nao Mai Yi Hao capsule:Nao Mai Yi Hao capsule plus conventional treatment

Placebo:Placebo plus conventional treatment

Eligibility

Sex/Gender

All

Age

30 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Subjects = 30 years; 2. Symptomatic cerebral artery stenosis after stent angioplasty; 3. Informed consent signed.

Exclusion criteria

Exclusion criteria: 1. Stent planted at bilateral vertebral arteries (V1) or subclavian arteries; 2. Refused treatment; 3. mRS?4 after stent angioplasty; 4. Currently receiving another trials; 5. Severe cardiac,respiratory, renal or hepatic insufficiency. 6. Severe mental disorder that can't take medicine regularly.

Design outcomes

Primary

Measure	Time frame
Stroke;Ischemic stroke;Transient ischemic stroke;Cerebral hemorrhage;Subarachnoid hemorrhage;	—

Secondary

Measure	Time frame
Modified Rankin Scale;Stroke-specific quality of life scale;cerebral artery restenosis;	—

Countries

China

Contacts

Public ContactYefeng Cai

Guangdong Provincial Hospital of Chinese Medicine

caiyefeng@126.com+86 15999978368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026